Johannes Levin

Johannes Levin has a diverse work experience in the field of neurodegeneration. Johannes currently serves as the Chief Medical Officer at MODAG since September 2019. In addition, they are a Professor for Clinical Neurodegeneration at Ludwig-Maximilians-Universität München, starting from December 2021. Prior to this, they worked as the Deputy Head of Clinical Research at the German Center for Neurodegenerative Diseases (DZNE) in Munich, starting from January 2018. Johannes also has extensive experience at LMU Klinikum München, where they worked as a Specialist in Neurology from March 2015 to November 2021, and as a Medical Assistant in Neurology from June 2006 to March 2015.

Johannes Levin has a diverse educational background in the field of medicine. Johannes attended Ludwig-Maximilians-Universität München from 1999 to 2006, where they obtained a Staatsexamen degree in Medizin. Additionally, they spent the academic year 2002-2003 at Universidad de Granada, although no specific degree was mentioned for this period.

In terms of additional certifications, Johannes obtained several qualifications in various specialized areas. In June 2018, they received a certification in Spezielle Neurologische Intensivmedizin from Bayerische Landesärztekammer. In June 2016, they obtained an EEG-Zertifikat from Deutsche Gesellschaft für klinische Neurophysiologie und funktionelle Bildgebung - DGKN. In July 2015, they completed a certification in fachgebundene genetische Beratung from Bayerische Landesärztekammer. Lastly, in April 2014, they acquired a qualification in qualifizierte Botulinumtoxin Therapie from the AG Botulinumtoxin der Deutschen Gesellschaft für Neurologie.